Evaluation of Mirtazapine and Folic Acid for Schizophrenia:
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Multicentre randomised double-blind, placebo-controlled 2x2 factorial trial investigating the
effects of adding mirtazapine and folic acid to existing therapy for patients with
schizophrenia
Phase:
Phase 4
Details
Lead Sponsor:
Capital Medical University
Treatments:
Folic Acid Mianserin Mirtazapine Vitamin B Complex